Chronic Pain

The findings are consistent with previous research about the efficacy of tanezumab for chronic low back pain.

While the opioid epidemic has had a devastating impact on American families, there is some hope that the future is bright.

In the final segment of the series, experts look ahead to how pain management will grow to treat the millions of burdened Americans.

In part 4 of our series, guideline authors and researchers relay the particularities of guiding and regulating the spread of still-necessary painkiller prescriptions.

According to a new report, males and older individuals are more susceptible to fall-related traumatic brain injury deaths.

In part 2, experts discuss how the public health crisis has reached a third decade, and what plans are to combat addiction problems.

The expert-led narrative series will seek to answer when and how the development of opioids led to a public health crisis.

The GSK-branded Advil will be available as a dual-action pain reliever later this year.

A clinical health psychologist discusses how to keep a patient-centered approach for treating chronic pain in today's healthcare environment.

The Proclaim XR recharge-free system provides relieve through a low-dose proprietary BurstDR stimulation waveform, which mimics natural brainwave patterns that change pain signals traveling from the spinal cord to the brain.

For chronic pain sufferers using opioids, policy changes have made it difficult to find new primary care providers — which investigators warn could have unintended consequences.

Contrary to earlier research, investigators found that medical cannabis laws do not reduce deaths caused by opioid overdoses.

The IB-Stim device uses electrical pulses to stimulate cranial nerves and reduce pain associated with irritable bowel syndrome.

Despite less than 2% of patients receiving surgery, they accounted for more than 25% of total expenditures within 1 year of diagnosis.

A short account of patients I’ve known and not loved over the years.

Investigators found that the prevalence of asthma in patients with opioid dependence was more than double the national prevalence.

An investigational non-opioid pain medication, tanezumab demonstrated statistically significant pain reduction at 16 weeks compared to placebo.

Reformulation of OxyContin to prevent it being dissolved and injected prompted switching to heroin and a surge in hepatitis C infections.

The Second Chance app from University of Washington investigators is seeking FDA consideration in the near future.

New research finds patients face a higher risk of pneumonia if they are taking opioids. The danger is even more pronounced for patients living with HIV.

For patients with chronic liver disease, opioid prescriptions are common, and high-risk prescriptions are associated with hepatic decompensation, especially ascites.

The SynchroMed II myPTM Personal Therapy Manager allows patients with chronic pain to manage unpredictable pain by delivering on-demand doses within limits set by their provider.

High Impact Chronic Pain encompasses individuals with chronic pain who also have a disability. Data collected in this study will help improve care for patients with HICP and guide future research.

A small study found that ketamine decreased symptoms of depression—investigators studied its effects in combination with the opioid-blocker naltrexone compared to a placebo.

The director of Pain Management and Palliative Care at the Englewood Hospital & Medical Center in Englewood, NJ, explains how analgesics may come to the forefront of pain management care.

New research finds that the prevalence of opioid use remained high during the study period from 2007 to 2016.

A CDC analysis found that overall drug overdose death rates increased by 21.5%, but those involving synthetic opioids more than doubled.

Researchers in Pennsylvania want to bolster the scientific case for the use of medical marijuana as an alternative to opioids.

Although LY2828360 failed as a therapeutic option for osteopathic pain in phase 2, it may be granted new life as a neuropathic pain treatment.

These findings could be the first step in the design of therapies that are better able to target specific receptors to exert therapeutic effects.